Mitchell Capital Management CO Novo Nordisk A S Transaction History

Mitchell Capital Management CO

$505 Million
Q1 2024

A detailed history of Mitchell Capital Management CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Mitchell Capital Management CO holds 22,539 shares of NVO stock, worth $3.13 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

22,539

Previous 21,286 5.89%

Holding current value

$3.13 Million

Previous $2.2 Million 31.43%

% of portfolio

0.57%

Previous 0.47%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$102.11 - $135.92 $127,943 - $170,307	1,253 Added 5.89%	22,539 $2.89 Million
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $59,339 - $71,284	-676 Reduced 3.08%	21,286 $2.2 Million
Q3 2023 Nov 03, 2023	BUY	$90.94 - $199.54 $993,883 - $2.18 Million	10,929 Added 99.06%	21,962 $2 Million
Q2 2023 Aug 08, 2023	BUY	$155.98 - $172.65 $37,903 - $41,953	243 Added 2.25%	11,033 $1.79 Million
Q1 2023 May 08, 2023	SELL	$132.34 - $159.14 $700,607 - $842,487	-5,294 Reduced 32.91%	10,790 $1.72 Million

Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $9,126 - $12,044	-89 Reduced 0.55%	16,084 $2.18 Million
Q3 2022 Oct 28, 2022	SELL	$95.28 - $116.93 $2,286 - $2,806	-24 Reduced 0.15%	16,173 $1.61 Million
Q2 2022 Jul 29, 2022	BUY	$103.24 - $121.81 $15,382 - $18,149	149 Added 0.93%	16,197 $1.81 Million
Q1 2022 Apr 29, 2022	BUY	$93.1 - $112.54 $71,407 - $86,318	767 Added 5.02%	16,048 $1.78 Million
Q4 2021 Jan 28, 2022	BUY	$95.88 - $117.08 $4,506 - $5,502	47 Added 0.31%	15,281 $1.71 Million
Q3 2021 Nov 02, 2021	BUY	$84.42 - $106.62 $23,975 - $30,280	284 Added 1.9%	15,234 $1.46 Million
Q2 2021 Aug 10, 2021	BUY	$67.66 - $84.76 $291,005 - $364,552	4,301 Added 40.39%	14,950 $1.25 Million
Q1 2021 Apr 29, 2021	BUY	$67.06 - $75.82 $153,165 - $173,172	2,284 Added 27.3%	10,649 $718,000
Q4 2020 Feb 08, 2021	BUY	$63.89 - $73.8 $48,300 - $55,792	756 Added 9.94%	8,365 $584,000
Q3 2020 Nov 10, 2020	BUY	$63.69 - $70.22 $19,807 - $21,838	311 Added 4.26%	7,609 $528,000
Q2 2020 Jul 29, 2020	BUY	$58.54 - $67.94 $127,090 - $147,497	2,171 Added 42.34%	7,298 $478,000
Q1 2020 May 06, 2020	BUY	$49.46 - $64.78 $253,581 - $332,127	5,127 New	5,127 $309,000

Others Institutions Holding NVO

# of Institutions

1,859

Shares Held

310M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $313B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Capital Management CO with notifications on news.

Account

Mitchell Capital Management CO Novo Nordisk A S Transaction History